Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OIC-16010250Phase 3Completed
Phase 3 trial of Nal-P-113 in gingival disease (2 arms), sponsored by School and Hospital of Stomatology, China Medical University. Primary endpoints: Plaque index, Plaque area and 4 more. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OIC-16010250.